Search Results 71-80 of 15141 for Break STD Taboo

1. Late-breaking abstract at SUO: Novel oncolytic immunotherapy shows promise for patients with bladder cancer

   A study demonstrated a potentially effective treatment for patients with bladder cancer who no longer respond to the common therapy,

2. A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors - Mayo Clinic

   The purpose of this study is to test a new drug plus standard treatment compared with standard treatment alone in patients with advanced head and neck squamous ...

3. Intraoperative microelectrode recordings using MAVEN compared to standard recording apparatuses - Mayo Clinic

   Clinical Trials · Intraoperative microelectrode recordings using MAVEN compared to standard recording apparatuses · More about research at Mayo Clinic · Mayo ...

4. A Study of BBI608 Combined with Standard Chemotherapies in Adult Patients who have Pancreatic Cancer - Mayo Clinic

   The purpose of this study is to assess the safety, tolerability, and best study dose of BBI608 when administered in combination with Gemcitabine and nab- ...

5. A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) - Mayo Clinic

   This trial incorporates both a novel up front GVHD therapy (sirolimus) as well as a novel BMT CTN developed acute GVHD biomarker test. Participation eligibility.

6. Comparison of the Atmo Motility Gas Capsule System to the Reference Standard - Mayo Clinic

   Clinical Trials · Comparison of the Atmo Motility Gas Capsule System to the Reference Standard · More about research at Mayo Clinic · Mayo Clinic Footer.

7. Discovery's Edge: Before the Bone Breaks - Mayo Clinic News Network

   Low bone density is one factor used to identify osteoporosis, and the gold standard measurement for bone density is the dual X-ray absorptiometry (DXA) scan.

8. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

   This is an open label, multi-center, Phase Ib dose escalation study of BBI608 administered in combination with either FOLFOX6 with and without bevacizumab, or ...

9. A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy - Mayo Clinic

   A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy ... standard therapy.

10. Withdrawal method (coitus interruptus) - Mayo Clinic

    The withdrawal method — pulling the penis out of the vagina before ejaculation — isn't the most effective birth control. Learn about the pros and cons.